AML in Saudi Arabia: Analysis According to the European LeukaemiaNet 2017 Cytogenetic Classification
Alabdulwahab, Amal S., Elsayed, Hussein G., Sherisher, Mohamed A., Zeeneldin, Ahmed, Elbjeirami, Wafa M.
Published in Clinical lymphoma, myeloma and leukemia (01.05.2020)
Published in Clinical lymphoma, myeloma and leukemia (01.05.2020)
Get full text
Journal Article
The Dana Farber consortium protocol (DFCP) vs. classic Hyper-CVAD for treatment of acute lymphoblastic leukemia in patients <50 Y. Single institution experience
Alabdulwahab, Amal S., Elsayed, Hussein G., Sherisher, Mohamed A., Zeeneldin, Ahmed, Alghamdi, Khalofa, Elbjeirami, Wafaa M.
Published in Leukemia research (01.09.2017)
Published in Leukemia research (01.09.2017)
Get full text
Journal Article
The Dana Farber Consortium Protocol (DFCP) for the treatment of adolescents and young adults with acute lymphoblastic leukemia: a single institution experience in Saudi Arabia
Alabdulwahab, Amal S, Elsayed, Hussein G, Sherisher, Mohamed Atia, Elbjeirami, Wafa M, Alieldin, Nelly
Published in Clinical lymphoma, myeloma and leukemia (01.05.2017)
Published in Clinical lymphoma, myeloma and leukemia (01.05.2017)
Get full text
Journal Article
Response to Imatinib in e13a2 Versus e14a2 BCR-ABL Fusion Transcripts in Chronic Myeloid Leukemia Saudi Patients
Elbjeirami, Wafa M., Alabdulwahab, Amal S., ELSayed, Hussein G., Abdelghaffer, Nermeen Adel, Elnagdi, Noha, Al-Jedani, Hanadi, Abd Allatif, Nahla, Al Shaikh, Abdulaziz, Al-Allaf, Faisal
Published in Blood (02.12.2016)
Published in Blood (02.12.2016)
Get full text
Journal Article